Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.519
+0.029 (5.90%)
At close: Nov 4, 2024, 4:00 PM
0.510
-0.010 (-1.83%)
After-hours: Nov 4, 2024, 5:50 PM EST
Sensei Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 13 | 17 | 46 | 177 | - | - | |
| Market Cap Growth | -48.64% | -62.21% | -74.21% | - | - | - | |
| Enterprise Value | -34 | -48 | -62 | 22 | - | - | |
| Last Close Price | 0.52 | 0.69 | 1.49 | 5.80 | - | - | |
| PE Ratio | - | -0.57 | -0.94 | -4.37 | - | - | |
| PB Ratio | 0.25 | 0.27 | 0.44 | 1.21 | - | - | |
| P/FCF Ratio | -0.64 | -0.54 | -1.16 | -5.50 | - | - | |
| P/OCF Ratio | -0.64 | -0.54 | -1.17 | -5.86 | - | - | |
| EV/EBITDA Ratio | 1.19 | 1.35 | 1.28 | -0.59 | - | - | |
| EV/EBIT Ratio | 1.14 | 1.30 | 1.24 | -0.58 | - | - | |
| EV/FCF Ratio | 1.51 | 1.49 | 1.59 | -0.67 | - | - | |
| Debt / Equity Ratio | 0.10 | 0.10 | 0.08 | 0.02 | 0.04 | -0.76 | |
| Debt / FCF Ratio | -0.21 | -0.19 | -0.20 | -0.07 | -0.04 | -1.86 | |
| Quick Ratio | 10.57 | 11.65 | 11.82 | 30.19 | 3.44 | 0.01 | |
| Current Ratio | 10.90 | 11.92 | 11.98 | 30.38 | 4.16 | 0.02 | |
| Return on Equity (ROE) | -45.17% | -40.52% | -38.88% | -45.31% | - | - | |
| Return on Assets (ROA) | -27.03% | -23.97% | -23.10% | -26.83% | -103.30% | -506.81% | |
| Return on Capital (ROIC) | -28.09% | -25.31% | -24.10% | -28.32% | -203.12% | - | |
| Earnings Yield | -227.31% | -197.14% | -106.15% | -20.73% | - | - | |
| FCF Yield | -186.76% | -186.17% | -85.96% | -18.19% | - | - | |
| Buyback Yield / Dilution | 18.11% | 8.96% | -10.80% | -1618.88% | -338.85% | -0.02% | |
| Total Shareholder Return | 18.11% | 8.96% | -10.80% | -1618.88% | -338.85% | -0.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.